Information Journal Paper
APA:
Copy. (2018). A ferutinin analogue with enhanced potency and selectivity against ER-positive breast cancer cells in vitro. BIOMEDICINE & PHARMACOTHERAPY, 105(-), 267-273. SID. https://sid.ir/paper/691690/en
Vancouver:
Copy. A ferutinin analogue with enhanced potency and selectivity against ER-positive breast cancer cells in vitro. BIOMEDICINE & PHARMACOTHERAPY[Internet]. 2018;105(-):267-273. Available from: https://sid.ir/paper/691690/en
IEEE:
Copy, “A ferutinin analogue with enhanced potency and selectivity against ER-positive breast cancer cells in vitro,” BIOMEDICINE & PHARMACOTHERAPY, vol. 105, no. -, pp. 267–273, 2018, [Online]. Available: https://sid.ir/paper/691690/en